Reading VVOS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track VVOS free→Reading VVOS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track VVOS free→QuarterlyIQ Insights · VVOS
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 5, 2026, the Company received a letter from the Listing Qualifications Staff of Nasdaq indicating that, based upon the closing bid price of the Common Stock, from April 23, 2026 to June 4, 2026, the Company is no longer in compliance with the requirement for continued listing on The Nasdaq Capital Market to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listing…
Unregistered Sales of Equity Securities. The information contained above under Item 1.01, to the extent applicable, is hereby incorporated by reference herein. Based in part upon the representations of V-Co 4, the offer and sale of the V-Co 4 Note was made in a private placement transaction exempt for registration in reliance on the exemption afforded by Section 4(a)(2) of the Securities Act and corresponding provisions of state securities or “blue sky” laws. Neither the V-Co 4 Note nor any s…
Entry into a Material Definitive Agreement. Streeterville Capital, LLC Exchange Agreement As previously reported, Vivos Therapeutics, Inc. (the “ Company ”) is a party to a senior secured loan transaction, dated June 9, 2025, with Streeterville Capital, LLC, a Utah limited liability company (“ Streeterville ”), pursuant to which Streeterville previously made a loan to the Company in the form of a Secured Promissory Note (the “ Streeterville Note ”) with an original principal face amount of $8…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained above in Item 1.01, to the extent applicable, is hereby incorporated by reference into this
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.